Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online June 22, 2006
Stem Cells Vol. 24 No. 10 October 2006, pp. 2192 -2201
doi:10.1634/stemcells.2006-0022; www.StemCells.com
© 2006 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2006-0022v1
24/10/2192    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bonde, S.
Right arrow Articles by Zavazava, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonde, S.
Right arrow Articles by Zavazava, N.

EMBRYONIC STEM CELLS: CHARACTERIZATION SERIES

Immunogenicity and Engraftment of Mouse Embryonic Stem Cells in Allogeneic Recipients

Sabrina Bondea, Nicholas Zavazavaa,b

aRoy J. and Lucille A. Carver College of Medicine, University of Iowa and Department of Veterans Affairs Medical Center;
bImmunology Graduate Program, Iowa City, Iowa, USA

Key Words. Embryonic stem cells • Engraftment • Apoptosis • Mixed chimerism • Retinoic acid early inducible-1

Correspondence: Nicholas Zavazava, M.D., Ph.D., University of Iowa Hospitals and Clinics, Department of Internal Medicine, 200 Hawkins Drive, C51-F, Iowa City, Iowa 52242, USA. Telephone: 319-384-6577; Fax: 319-356-8280; e-mail: Nicholas-zavazava{at}uiowa.edu

Received January 11, 2006; accepted for publication June 16, 2006.
First published online in STEM CELLS EXPRESS   June 22, 2006.



Embryonic stem cells (ESCs) are pluripotent and therefore able to differentiate both in vitro and in vivo into specialized tissues under appropriate conditions, a property that could be exploited for cellular therapies. However, the immunological nature of these cells in vivo has not been well understood. In vitro, mouse-derived ESCs fail to stimulate T cells, but they abrogate ongoing alloresponses by a process that requires cell-cell contact. We further show that despite a high expression of the NKG2D ligand retinoic acid early inducible-1 by mouse ESCs, they remain resistant to natural killer cell lysis. In vivo, allogeneic mouse ESCs populate the thymus, spleen, and liver of sublethally irradiated allogeneic host mice, inducing apoptosis to T cells and establishing multilineage mixed chimerism that significantly inhibits alloresponses to donor major histocompatibility complex antigens. Immunohistochemical imaging revealed a significant percentage of ESC-derived cells in the splenic marginal zones, but not in the follicles. Taken together, the data presented here reveal that nondifferentiated mouse embryonic stem cells are non-immunogenic and appear to populate lymphoid tissues in vivo, leading to T-cell deletion by apoptosis.




This article has been cited by other articles:


Home page
Stem CellsHome page
D. C. Wu, A. S. Boyd, and K. J. Wood
Embryonic Stem Cells and Their Differentiated Derivatives Have a Fragile Immune Privilege but Still Represent Novel Targets of Immune Attack
Stem Cells, August 1, 2008; 26(8): 1939 - 1950.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K.-M. Chan, S. Bonde, H. Klump, and N. Zavazava
Hematopoiesis and immunity of HOXB4-transduced embryonic stem cell-derived hematopoietic progenitor cells
Blood, March 15, 2008; 111(6): 2953 - 2961.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 2006 by AlphaMed Press.